English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

SUMMARY With the advance of genetics, it is necessary that the physicians know the importance for the women to carry a BCRA1 and BRCA2 mutations. An extensive review about the evidence of prophylactic oophorectomy in these patients is performed. Currently, the experience published is enough for the development of clinical guidelines for patients who carry a BRCA1 and BRCA2 or if they are looking for an advice in relation to the risk of develops ovarian cancer. Based on evidence, prophylactic oophorectomy does protect against the development of ovarian and breast cancer in women who carry BCRA1 and BRCA2 mutations.

revista chilena de obstetricia y ginecología

¿SE JUSTIFICA LA OOFORECTOMÍA, COMO MEDIDA PROFILÁCTICA EN LA DISMINUCIÓN DEL RIESGO DE CÁNCER DE OVARIO Y DE MAMA, EN LAS PACIENTES PORTADORAS DE MUTACIONES EN LOS GENES BRCA1 O BRCA2?